Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
181 NOK | +3.43% | +2.84% | -15.42% |
04-25 | Transcript : Medistim ASA, Q1 2024 Earnings Call, Apr 25, 2024 | |
04-24 | Medistim ASA Approves Dividend for the Year 2023, Payable on May 6, 2024 | CI |
Sales 2024 * | 539M 48.93M 66.35M | Sales 2025 * | 563M 51.17M 69.38M | Capitalization | 3.2B 291M 395M |
---|---|---|---|---|---|
Net income 2024 * | 107M 9.72M 13.18M | Net income 2025 * | 118M 10.72M 14.54M | EV / Sales 2024 * | 5.81 x |
Net cash position 2024 * | 78M 7.09M 9.61M | Net cash position 2025 * | 119M 10.81M 14.66M | EV / Sales 2025 * | 5.48 x |
P/E ratio 2024 * |
29.8
x | P/E ratio 2025 * |
27.1
x | Employees | 151 |
Yield 2024 * |
2.57% | Yield 2025 * |
1.93% | Free-Float | 74.3% |
Latest transcript on Medistim ASA
1 day | +3.43% | ||
1 week | +2.84% | ||
Current month | -2.69% | ||
1 month | -5.48% | ||
3 months | -13.40% | ||
6 months | -4.74% | ||
Current year | -15.42% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 60 | 09-08-31 | |
Director of Finance/CFO | - | 00-12-31 | |
Anne Waaler
CTO | Chief Tech/Sci/R&D Officer | 68 | 15-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chairman | 76 | 99-12-31 | |
Director/Board Member | 54 | 23-03-31 | |
Lars Rønn
BRD | Director/Board Member | 60 | 09-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-29 | 181 | +3.43% | 2 324 |
24-04-26 | 175 | +0.57% | 2,701 |
24-04-25 | 174 | -6.70% | 29,751 |
24-04-24 | 186.5 | +5.07% | 4,654 |
24-04-23 | 177.5 | +0.85% | 4,082 |
Real-time Oslo Bors, April 29, 2024 at 05:22 am
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.42% | 290M | |
+8.07% | 219B | |
+6.59% | 183B | |
+11.26% | 133B | |
+26.57% | 108B | |
+2.62% | 63.06B | |
+13.35% | 52.02B | |
-0.62% | 48.2B | |
-0.93% | 40.37B | |
+11.54% | 39.35B |
- Stock Market
- Equities
- MEDI Stock